Literatur
Mogensen, O.: Prognostic value of CA 125 in advanced ovarian cancer Gynecologic Oncology 44, 207–212
Hall, P.A.:, Levison, D.A.:, Woods, A.L., Yu, C.C-W., Kellock, D.B., Watkins, J.A., Barnes, D.M., Gillet, C.E., Camplejohn, R., Dover, R., Waseem, N.H., Lane, D.P.: Proliferating cell nuclear antigen (PCNA) immunlocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms J. Path. 162, 285–294, 1990
Fioretti, P., Gadducci, A., Ferdeghini, M., Prontera, C., Malagnino, G., Facchini, V., Mariani, G., Bianchi, R.: The concomitant determination of different serum tumor markers in epithelial ovarian cancer: Relevance for monitoring the response to chemotherapy and follow-up of patients Gynecol. Oncol. 44, 155–160, 1992
Gaducci, A., Ferdeghini, M., Prontera, C., Moretti, L., Mariani, G., Bianchi, R., Fioretti, P.: The cocomitant determination of different tumor markers in patients with epithelial ovaria cancer and benign ovarian masses: Relevance for differential diagnosis Gynec. Oncol. 44, 147–154, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ewald, R., Minguillon, C., Lichtenegger, W. et al. CA 125 und PNCA (Proliferating Cell Nuclear Antigen) beim Ovarial-Ca, ein 10-jähriger klinischer Verlauf. Arch Gynecol Obstet 254, 938–940 (1993). https://doi.org/10.1007/BF02266244
Issue Date:
DOI: https://doi.org/10.1007/BF02266244